Related Experiment Video
Updated: Oct 15, 2025

In vivo Evaluation of Mucociliary Clearance in Mice
Published on: December 18, 2020
The relationship between Covid-19 and mucociliary clearance
Mehmet Erkan Kahraman1, Fatih Yüksel1, Yaşar Özbuğday1
1Department of Otolaryngology, Konya City Hospital, Konya, Turkey.
COVID-19 infection was found to significantly prolong nasal mucociliary clearance (MCC) time in patients. This study suggests corticosteroids may aid recovery by improving MCC duration and reducing symptoms.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Respiratory Physiology
Background:
- The impact of COVID-19 on nasal mucociliary clearance (MCC) remains largely uncharacterized.
- Understanding this relationship is crucial for managing respiratory symptoms and recovery.
Purpose of the Study:
- To investigate the association between COVID-19 infection and nasal MCC.
- To explore how factors like smoking, symptoms, and treatment influence this relationship.
Main Methods:
- A comparative study involving 36 hospitalized COVID-19 patients and 36 healthy controls.
- Nasal MCC was assessed using the standardized Saccharin test in both groups.
Main Results:
- No significant differences in age or gender were observed between the COVID-19 patient group and the control group.
- Nasal MCC time was significantly prolonged in COVID-19 patients (19.18 ± 10.84 min) compared to controls (13.78 ± 8.18 min; p=0.003).
Conclusions:
- COVID-19 infection independently prolongs nasal MCC time, irrespective of patient age.
- Corticosteroid therapy is recommended for COVID-19 treatment due to potential benefits in symptom relief and improved nasal MCC duration.
More Related Videos
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation